Fighting Cancer with
A Single Draw of Blood
Lucence develops cutting-edge genomic tests
for cancer detection and treatment selection.
How Lucence is Deploying its Ultrasensitive Non-Invasive Diagnostics Technology Platforms to Help Fight COVID-19:
University Study Reports 36% Greater Detection of SARS-CoV-2 using Lucence's SAFER Saliva Sample Kit Compared To Standard Swabs
Find out more here about how Lucence can help achieve safer, more accurate and more affordable mass-testing and quicker contact tracing by COVID-19 labs (available only in specific worldwide markets)
Next-generation cancer care today
An emerging medical discipline, Genomic Medicine uses your genomic information for diagnostic or therapeutic decision-making, enabling more effective treatments and better health outcomes.
Every cancer is different.
So is our approach.
No two people are the same, and neither are their cancers. This means that even if two people are diagnosed with the same cancer, they may respond differently to the same treatment. Therefore, the first step to fighting cancer begins with uncovering the mutations that drive each person’s cancer.
Genomic medicine is a new medical approach which customizes healthcare to each person’s unique genetic make-up. Our genome-based diagnostic tests allow doctors to see the clearer picture, and make more informed decisions for better cancer care.
The future of fighting cancer.
Detects cancer before symptoms show and checks for genetic risk of developing cancer. Early detection will enable earlier treatment and improve survival rates.
Detects mutations in the tumor that will respond well to specific targeted drugs. This helps physicians to tailor drug treatments to the individual patient.